Inactive Instrument
Company Scibase AB Swiss Exchange
Stocks
SE0007045414
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| 03-02 | SciBase Wins US FDA Nod for Skin Cancer Detection Device Label Expansion | MT |
| 11-07 | SciBase, Castle Biosciences Expand License Deal, Secures SEK20 Million Loan | MT |
Business description: Scibase AB
Executive Committee: Scibase AB
| Manager | Title | Age | Since |
|---|---|---|---|
Pia Renaudin
CEO | Chief Executive Officer | 59 | 2023-09-30 |
Michael Colérus
DFI | Director of Finance/CFO | 64 | 2013-12-31 |
| Chief Tech/Sci/R&D Officer | - | - | |
| Chief Tech/Sci/R&D Officer | - | - | |
Linn Olsen
COO | Chief Operating Officer | 49 | - |
Composition of the Board of Directors: Scibase AB
| Director | Title | Age | Since |
|---|---|---|---|
Diana Ferro
BRD | Director/Board Member | 60 | 2017-05-15 |
Jesper Høiland
CHM | Chairman | 65 | 2024-06-12 |
| Director/Board Member | 68 | - | |
Robert Molander
BRD | Director/Board Member | 61 | - |
Company details: Scibase AB
Medical Diagnostic & Testing Equipment
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.95% | +1.16% | +3.42% | -29.95% | 16.36B | |
| +5.89% | +23.51% | +46.13% | +99.78% | 1.78B | |
| +0.39% | +32.34% | -39.55% | -78.20% | 1.24B | |
| +0.06% | +3.85% | -28.16% | +34.59% | 1.14B | |
| +1.31% | +4.95% | -25.50% | -53.00% | 640M | |
| +0.21% | +3.42% | -36.59% | -56.57% | 582M | |
| -0.66% | +3.11% | +20.57% | -54.11% | 447M | |
| +1.79% | +0.16% | -55.21% | -60.49% | 382M | |
| +2.52% | +7.65% | -20.43% | -18.30% | 362M | |
| Average | +1.03% | +7.61% | -15.04% | -24.03% | 2.55B | |
| Weighted average by Cap. | +0.39% | +4.51% | +0.01% | -21.39% |
- Stock Market
- Stocks
- Stock
- Stock
- Company Scibase AB
Select your edition
All financial news and data tailored to specific country editions
